Skip to main content
OpenTrials
Recruiting

NCT Number: NCT03967600

Clinical and Biological Characteristics of Hidradenitis Suppurativa

Hidradenitis suppurativa (HS) is a common and debilitating skin disease that is poorly understood and understudied. As a result, little is known about disease prognosis and few effective treatments exist for this condition. This prospective observational cohort study aims to comprehensively characterize the clinical and biological features of HS. The results of this research will provide a basis for the development of an HS clinical classification system and identification of potential treatments for HS.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Hidradenitis Suppurativa Bacterial Infections Bacterial Infections and Mycoses Hidradenitis Infections Skin Diseases Skin Diseases, Bacterial Skin Diseases, Infectious Skin and Connective Tissue Diseases Suppuration Sweat Gland Diseases

Age range

13 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University of California, San Francisco

San Francisco, California, 94115, United States

Location status: Recruiting

Location contact

Haley B Naik, MD, MHSc, FAAD

PRINCIPAL_INVESTIGATOR

Maia Paul, MPH

CONTACT

[email protected]

415-502-4741

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Hidradenitis Suppurativa Patients

Inclusion criteria

  • Age 13 years or older
  • Diagnosis of HS clinically-confirmed by a physician

Exclusion criteria

  • Inability to give informed consent or have a parent/guardian who is able and willing to give informed consent.

Healthy Volunteer

Inclusion criteria

  • No history of chronic skin conditions
  • No recent history of antibiotic use

Exclusion criteria

  • Inability to give informed consent or have a parent/guardian who is able and willing to give informed consent.

Treatment and study plan

Primary outcomes

  1. The primary aim of this study is to identify clinical and biologic characteristics of hidradenitis suppurativa.

    Time frame: 2016-2026

Secondary outcomes

  1. Secondary aims include correlating alterations in clinical and biological characteristics with disease status, and identifying genetic variants that predict disease progression or response to therapy.

    Time frame: 2016-2026

Study contacts

Contact information is provided by the study sponsor or research team.

Kaelin Chatterley

CONTACT

[email protected]

415-961-3786

Sponsors and collaborators

Lead sponsor

University of California, San Francisco

Other

Registry information

Important dates

Study start
2016
Primary completion
2026
Study completion
2026
First posted
May 30, 2019
Registry last updated
May 4, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.